| IND | indomethacin; industrial medicine; investigational new drug |
|---|---|
| ind | indirect; induction |
| ref | ind refractive index |
| REV | reticuloendotheliosis virus |
| ReV | regulator of virion |
| IND | Indomethacin |
|---|---|
| IND | Intestinal Neuronal Dysplasia |
| IND | Investigational New Drug |
| IND | Investigational New Drug Application |
| RRE | REV response element |
| gene products, rev | Trans-acting nuclear proteins whose functional expression are required for HIV viral replication. Specifically, the rev gene products are required for processing and translation of the HIV gag and env mRNAs, and thus rev regulates the expression of the viral structural proteins. Rev can also regulate viral regulatory proteins. A cis-acting antirepression sequence (car) in env, also known as the rev-responsive element (rre), is responsive to the rev gene product. Rev is short for regulator of virion. (12 Dec 1998) |
|---|---|
| genes, rev | DNA sequences that form the coding region for a protein that regulates the expression of the viral structural and regulatory proteins in human immunodeficiency virus (HIV). Rev is short for regulator of virion. (12 Dec 1998) |
| rev | <molecular biology> A regulatory protein produced by HIV within infected cells. Rev helps transport HIV RNA sequences (messenger RNA) out from the nucleus into the cells cytoplasm, where it directs construction of proteins for new virus particles. (11 Jan 1998) |
| ind | Investigational New Drug An IND application containing laboratory study results of the drug candidate is submitted to the FDA to request permission to conduct studies in humans. (14 Nov 1997) |
| ind status | Status given an experimental drug after the FDA approves an application for testing it in people. (09 Oct 1997) |
| treatment ind | An FDA-approved program that allows a physician to procure an experimental drug for seriously ill patients who have no other treatment options in exchange for data on the safety and perhaps the effectiveness of the drug. See: compassionate use, parallel track, expanded access. (09 Oct 1997) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|